GoldenGolden
Advanced Search
Paradigm Diagnostics

Paradigm Diagnostics

Paradigm Diagnostics is a Phoenix, Arizona-based medical diagnostics company developing small specimen and fine needle aspirates.

Through Next-Gen Sequencing (NGS), and other biomarker analysis, the Paradigm Cancer Diagnostic (PCDx) test offered by Paradigm Diagnostics is able to provide genomic and proteomic information about a patient’s cancer, helping the oncologist personalize each patient’s course of treatment.

Timeline

May 21, 2019
Paradigm Diagnostics raises a $15,000,000 series B round.
February 16, 2017
Paradigm Diagnostics raises a $7,000,000 series B round.
November 16, 2016
Paradigm Diagnostics raises a $7,000,000 series B round from Mesa Verde Venture Partners.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.